Mr. Liles focuses his practice on fraud defense, internal audits / investigations, compliance and regulatory matters. Mr. Liles has represented a wide variety of clients in civil and criminal proceedings, complex civil litigation, and in connection with reviews conducted under non-profit and Sarbanes-Oxley compliance requirements.
Before entering private practice, Mr. Liles served as Deputy Director for Legal Programs at the United States Department of Justice (DOJ), Executive Office for United States Attorneys (EOUSA). Prior to serving in Washington, D.C., he worked as an Assistant United States Attorney in the Southern District of Texas, Houston office, where he primarily handled False Claims Act matters and cases.
Mr. Liles was subsequently appointed as Chief of the Financial Litigation Unit for the Southern District of Texas. Working in this capacity, he was responsible for managing a substantial accounts receivable portfolio, representing hundreds of millions of dollars in collections amounts owned to the government by individuals and corporations. Mr. Liles managed a staff of attorneys and support personnel tasked with collecting sums owed to DOJ and its client agencies.
In 1997, he was detailed to the EOUSA in Washington, D.C. as its first National Health Care Fraud Coordinator. In this capacity, he advised Assistant United States Attorneys around the country on civil and criminal health fraud statutes, schemes, investigative tools, privacy concerns, and compliance issues. Mr. Liles was instrumental in implementing DOJ guidance on the judicious use of the False Claims Act.
Mr. Liles has taught and lectured at more than 50 national conferences and seminars to DOJ prosecutors, investigators, auditors, and industry representatives on a variety of civil and criminal fraud and regulatory issues. He serves as faculty for the Georgetown University / National Institute of Trial Advocacy.
In 1999, Mr. Liles received a Director’s Award (Executive Office for United States Attorney’s highest award). Mr. Liles’ management background provides a firm understanding of the real-life operational and regulatory problems faced by corporations.
Recent Matters Handled Include:
Represented corporate clients in connection with Medicare overpayment audits conducted by carriers, intermediaries, Program Safeguard Contractors, and Zone Program Integrity Contractors. Aggressively worked to have statistical extrapolation of alleged damages dismissed.
Directed internal audit of non-profit corporate operations, policies and procedures to better ensure statutory and regulatory compliance.
Conducted internal investigation of alleged malfeasance of corporate employees. Provided recommendations for the implementation of safeguards to better prevent improper employee conduct.
Represented physicians in connection with investigations and disciplinary actions taken by state medical practice boards.
Worked with medical group management companies to help ensure that the provider groups they serve remain compliant with statutory and regulatory requirements.
Serve as outside General Counsel for national third-party billing association.
Serve as outside Compliance Officer for health care providers.
Represented international bank in connection with fraud investigation conducted by the Department of Justice.
Workedwith corporate clients to properly incorporate privacy provisions into a Client’s overall effective compliance strategy.
Advised a variety of specialty health care providers in the areas of oncology, pain management, urology, ambulance services, cardiology, physical / occupational and speech therapy, and durable medical equipment, in fraud and compliance matters.
Provided assessment and advice to corporate clients on proposed business models, addressing both the prohibition against self-referrals and federal Anti-Kickback Act concerns.
Represented individual and corporate health care providers in ongoing litigation under the False Claims Act, addressing concerns raised by the Department of Justice.
Managed large document productions on behalf of corporate clients in response to Department of Justice, state and federal agency subpoenas.
Advised investors and investment companies with respect to health care sector issues and the possible impact of health care fraud enforcement activities.
